• Most Popular
  • Most Shared

India Sun Pharma gets U.S. FDA nod for benzonatate

Sun Mar 23, 2008 11:26pm EDT

Stocks

   

MUMBAI, March 24 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO) said it has approval from the U.S. Food and Drug Administration to market benzonatate capsules, the generic version of Forest Laboratories' (FRX.N) Tessalon.

The drug, used to treat cough, common cold, pneumonia and other lung infections, would be available in 100 mg and 200 mg dosages, the firm said in a statement.

Benzonatate had annual sales of about $40 million in the United States, Sun said, adding it would start selling the drug shortly. (Reporting by Narayanan Somasundaram)



More from Reuters

This heart-wrenching picture of a mother and child at an an emergency feeding centre in in Tahoua, Niger, won international acclaim for incorporating beauty, horror and despair. Taken on August 1, 2005 by Finbarr O'Reilly.

Pictures of the Decade

    Pictures
    A gold miner inspects a rock while digging a pit at the Chudja mine in the Kilomoto concession near the village of Kobu, 100 km (62 miles) from Bunia in northeastern Congo, February 23, 2009. REUTERS/Finbarr O'Reilly
    OUTLOOK 2010:

    Unsafe havens, big returns?

    Underdeveloped, illiquid, unstable ... if you can stomach the risks, these diamonds in the rough look set to pay off.  Full Article 

    Global Investing
    A student receives a H1N1 vaccine injection at a hospital in Suining, Sichuan province November 11, 2009. Credit: REUTERS/Stringer

    Pictures of the Year

    A girl receiving the H1N1 vaccine and breathtaking saves in a soccer game are among the indelible Reuters images of the year.  Slideshow 

    Pictures